LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Clinical trials for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC trials appear
Sign up with your email to follow new studies for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for rare, Life-Threatening immune disorder
Disease control Recruiting nowThis study is testing whether a drug called Golidocitinib can safely and effectively treat hemophagocytic lymphohistiocytosis (HLH), a rare and severe immune system disorder. It will involve 28 patients aged 14-70 who have HLH and are not currently suitable for a stem cell transp…
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists hunt for clues in devastating immune storm disorder
Knowledge-focused Recruiting nowThis study aims to learn why some adults develop a severe, life-threatening immune system disorder called secondary hemophagocytic lymphohistiocytosis (sHLH). Researchers will observe 300 adults already diagnosed with sHLH over time, collecting blood samples and health informatio…
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC